Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
出版年份 2014 全文链接
标题
Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
作者
关键词
YKL-40, Esophageal cancer, ESCC
出版物
BMC CANCER
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-07-07
DOI
10.1186/1471-2407-14-490
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Serum YKL-40 Level Is Associated with the Chemotherapy Response and Prognosis of Patients with Small Cell Lung Cancer
- (2014) Chun-Hua Xu et al. PLoS One
- Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer
- (2013) Mu-qing Zhou et al. BMC CANCER
- YKL-40 expression could be a poor prognostic marker in the breast cancer tissue
- (2013) Eun Joo Kang et al. TUMOR BIOLOGY
- microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma
- (2012) Yiqiang Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy
- (2012) Yi Hu et al. Chinese Journal of Cancer
- Elevated Serum YKL-40 Level Predicts Poor Prognosis in Hepatocellular Carcinoma After Surgery
- (2011) Cheng-Bao Zhu et al. ANNALS OF SURGICAL ONCOLOGY
- Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation and other cancer markers
- (2011) R Shao et al. BRITISH JOURNAL OF CANCER
- Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China
- (2011) Yue Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature
- (2011) C Taccioli et al. ONCOGENE
- Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers
- (2011) Paweł Stawerski et al. PATHOLOGY RESEARCH AND PRACTICE
- High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer
- (2010) In Keun Choi et al. ACTA ONCOLOGICA
- The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer
- (2010) L. Zou et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
- (2010) Ina Thöm et al. CANCER
- Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
- (2010) Jun Dong et al. Journal of Translational Medicine
- YKL-40 tissue expression and plasma levels in patients with ovarian cancer
- (2009) Estrid VS Høgdall et al. BMC CANCER
- Overexpression of YKL-40 is an independent prognostic marker in gastric cancer
- (2009) Jiong Bi et al. HUMAN PATHOLOGY
- Prognostic relevance of Centromere protein H expression in esophageal carcinoma
- (2008) Xian-Zhi Guo et al. BMC CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started